Company / Operating Cash Flow
IGC Pharma, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$4.8M
FY2025
5-year range
-$10.8M / -$4.8M
FY2021-FY2025
Trend
+32.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has increased for 3 consecutive years, from -$11M in FY2022 to -$5M in FY2025.
Based on SEC 10-K filings.
-$5M in FY2025.
Improved from -$7M to -$5M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- IGC Pharma, Inc.'s operating cash flow has grown for 3 consecutive years.
- In FY2025, operating cash flow increased 32.0% year-over-year.
- Peak operating cash flow was recorded in FY2017.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.8M | +32.0% |
| FY2024 | -$7.0M | +5.6% |
| FY2023 | -$7.5M | +30.9% |
| FY2022 | -$10.8M | -24.5% |
| FY2021 | -$8.7M | -160.6% |
| FY2020 | -$3.3M | -72.4% |
| FY2019 | -$1.9M | -38.8% |
| FY2018 | -$1.4M | -782.1% |
| FY2017 | -$157.7K | +93.9% |
| FY2016 | -$2.6M | -48.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026